Olema Pharmaceuticals Inc
OLMA
NASDAQ
Biotechnology
$10.63
USD
+0.12 (+1.14%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $919.60M
Volume 1.2M
Price Target
$36.00 – $36.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $36.00 and a min estimate of $36.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$36.00
-$7.3 vs prior
Implied Upside
+238.7%
-69.0% vs prior
Analyst Covering
1
-5 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
14%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Emily Bodnar | HC Wainwright & Co. | Buy | Maintained | 4 days ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
GERN
Geron Corp
$1.47
▼ -4.2%
AURA
Aura Biosciences Inc
$7.69
▲ +0.5%
DSGN
Design Therapeutics Inc
$14.83
▲ +3.1%
JANX
Janux Therapeutics Inc
$16.12
▲ +0.8%
ANNX
Annexon Inc
$5.29
▲ +0.6%
CADL
Candel Therapeutics Inc
$11.72
▼ -0.7%
CLYM
Climb Bio Inc
$16.33
▲ +10.9%
KURA
Kura Oncology Inc
$10.86
▲ +7.6%
FTH
Faeth Therapeutics, Inc
$32.34
▲ +13.3%